Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: Brian Malloy who wrote (536)	1/22/1998 3:01:00 PM
From: Pseudo Biologist	Respond to of 1972

Thanks, Brian. I must have read that post too quickly. Malaria is interesting because Vical is a bit more directly involved, and thus we may be able to follow progress much better than with the cloak-and-dagger Merck act. We know in broad terms about Merck's work, what we (I?) don't know about is clinical progress, which is what really moves these stocks. Nancy's post on her conversation with Vical suggests we won't do much better re. information in the near future either, as far as Merck is concerned. PB P.S. Did you see the MegaBios release today? Anything to be concerned about? Must confess I know next to zero of MBIO.